Industry leader with expertise in building successful biotechnology companies Copenhagen, Denmark and Boston, US 13th September 2021 – Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today announced the appointment of Dr. Donald Nicholson, as independent Chair of its Board of Directors. Dr. Nicholson has deep experience across both […]
This author has not written his bio yet.
But we are proud to say that neurogentx contributed 2 entries already.
Entries by neurogentx
Financing co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB Developing small molecules to repair neuronal dysfunction and resolve neuroinflammation Innovative drug discovery platform leveraging insights from novel targets and pathways, resilience to neurodegeneration and all-in-human validation Copenhagen, […]